Double negative regulatory T cells in transplantation and autoimmunity: Recent progress and future directions

Journal of Molecular Cell Biology

Volumn 4, Issue 1, 2012, Pages 48-58

  Juvet, Stephen C ^a,b   Zhang, Li ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

autoimmunity; double negative T cells; graft versus host disease; regulatory T cells; transplantation; type 1 diabetes mellitus

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; BONE MARROW; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL TRANSPLANTATION; DIABETES MELLITUS; GRAFT DYSFUNCTION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; ONTOGENY; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; BIOLOGICAL MARKERS; CELL TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; INTERFERON-GAMMA; ISOANTIGENS; MICE; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

RODENTIA;

EID: 84863078551     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjr043     Document Type: Review

References (98)

1. Anderson, G., and Jenkinson, E.J. (2001). Lymphostromal interactions in thymic development and function. Nat. Rev. Immunol. 1, 31-40. (Pubitemid 33741973)
2. Bendelac, A., Savage, P.B., and Teyton, L. (2007). The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336. (Pubitemid 46697911)
3. -T cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin. Immunol. 104, 21-30. (Pubitemid 34856505)
4. + regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17, 638-642. (Pubitemid 41506909)
5. Brok, H.P., Heidt, P.J., van der Meide, P.H., et al. (1993). Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Immunol. 151, 6451-6459.
6. -) alpha/beta T cell receptor-bearing cells. J. Immunol. 145, 4046-4052.
7. Chen, W., Ford, M.S., Young, K.J., et al. (2003a). Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J. Immunol. 170, 1846-1853. (Pubitemid 36197401)
8. Chen, W., Ford, M.S., Young, K.J., et al. (2003b). Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplant. Proc. 35, 2479-2480. (Pubitemid 37378037)
9. Chen, W., Zhou, D., Torrealba, J.R., et al. (2005). Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells. J. Immunol. 175, 3409-3416. (Pubitemid 41170564)
10. Chen, W., Diao, J., Stepkowski, S.M., et al. (2007). Both infiltrating regulatory T cells and insufficient antigen presentation are involved in long-term cardiac xenograft survival. J. Immunol. 179, 1542-1548.
11. Chu, J.L., Ramos, P., Rosendorff, A., et al. (1995). Massive upregulation of the Fas ligand in lpr and gld mice: Implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181, 393-398.
12. - T cells control intracellular bacterial infections both in vitro and in vivo. J. Exp. Med. 202, 309-319. (Pubitemid 41043826)
13. - double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. J. Immunol. 184, 5791-5801.
14. + T cells and display an inflammatory effector phenotype. J. Immunol. 183, 4675-4681.
15. Crispin, J.C., Oukka, M., Bayliss, G., et al. (2008). Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181, 8761-8766.
16. - (double negative) T cells: Saviours or villains of the immune response? Biochem. Pharmacol. 82, 333-340.
17. + cells. J. Immunol. 186, 6788-6797.
18. Dugas, V., Beauchamp, C., Chabot-Roy, G., et al. (2010). Implication of the CD47 pathway in autoimmune diabetes. J. Autoimmun. 35, 23-32.
19. -4-8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes. PLoS One 5, e11427.
20. - thymocytes. Int. Immunol. 2, 157-163. (Pubitemid 20050414)
21. + regulatory cell activation and function by dendritic cells. Int. Immunol. 16, 1769-1780. (Pubitemid 40003865)
22. - double-negative regulatory T cells. Blood 105, 2828-2835. (Pubitemid 40446276)
23. + regulatory T cells. Nat. Immunol. 4, 330-336. (Pubitemid 36432314)
24. Ford, M.S., Young, K.J., Zhang, Z., et al. (2002). The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J. Exp. Med. 196, 261-267. (Pubitemid 34787516)
25. + T cell precursors. J. Immunol. 177, 2803-2809. (Pubitemid 44277795)
26. Ford, M.S., Chen, W., Wong, S., et al. (2007). Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. Eur. J. Immunol. 37, 2234-2241. (Pubitemid 47250215)
27. Ford McIntyre, M.S., Young, K.J., Gao, J., et al. (2008). Cutting edge: In vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression. J. Immunol. 181, 2271-2275.
28. Ford McIntyre, M.S., Gao, J.F., Li, X., et al. (2010). Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression. Int. Immunopharmacol. 11, 597-603.
29. Gao, J.F., McIntyre, M.S., Juvet, S.C., et al. (2011). Regulation of antigen-expressing dendritic cells by double negative regulatory T cells. Eur. J. Immunol. 41, 2699-2708.
30. Giese, T., and Davidson, W.F. (1992). Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J. Immunol. 149, 3097-3106.
31. Giese, T., and Davidson, W.F. (1994). Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J. Immunol. 152, 2000-2010. (Pubitemid 24075734)
32. + double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. J. Immunol. 151, 597-609. (Pubitemid 23215725)
33. + regulatory T cells utilize FasL as a mechanism to restrict DC priming functions in cutaneous immune responses. Eur. J. Immunol. 40, 2006-2015.
34. Gran, B., Chu, N., Zhang, G.X., et al. (2004). Early administration of IL-12 suppresses EAE through induction of interferon-gamma. J. Neuroimmunol. 156, 123-131. (Pubitemid 39304192)
35. + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 100, 10878-10883. (Pubitemid 37140121)
36. Halder, R.C., Kawamura, T., Bannai, M., et al. (2001). Intensive generation of NK1.1-extrathymic T cells in the liver by injection of bone marrow cells isolated from mice with a mutation of polymorphic major histocompatibility complex antigens. Immunology 102, 450-459. (Pubitemid 32322957)
37. + double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. J. Immunol. 171, 2421-2426. (Pubitemid 37025549)
38. Hammond, D.M., Nagarkatti, P.S., Gote, L.R., et al. (1993). Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. J. Exp. Med. 178, 2225-2230. (Pubitemid 23344882)
39. He, K.M., Ma, Y., Wang, S., et al. (2007). Donor double-negative Treg promote allogeneic mixed chimerism and tolerance. Eur. J. Immunol. 37, 3455-3466.
40. Hill, M., Thebault, P., Segovia, M., et al. (2011). Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferongamma and epstein-barr virus-induced gene 3. Am. J. Transplant. 11, 2036-2045.
41. - T cells in autoimmune- prone non-obese diabetic mice. Immunol. Cell Biol. 88, 771-780.
42. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196, 389-399. (Pubitemid 34875667)
43. Hong, S., Wilson, M.T., Serizawa, I., et al. (2001). The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7, 1052-1056. (Pubitemid 32937387)
44. Hudrisier, D., Clemenceau, B., Balor, S., et al. (2009). Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis. J. Immunol. 183, 6102-6113.
45. - T cells with regulatory functions dominates the mouse female genital tract. J. Immunol. 170, 1659-1666. (Pubitemid 36197379)
46. Joly, E., and Hudrisier, D. (2003). What is trogocytosis and what is its purpose? Nat. Immunol. 4, 815. (Pubitemid 37098646)
47. - antigen-specific suppressor T cell clones. J. Immunol. 162, 5860-5867. (Pubitemid 29314939)
48. Kinjyo, I., Gordon, S.M., Intlekofer, A.M., et al. (2010). Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin. J. Immunol. 185, 7151-7155.
49. Kolb, H.J. (2008). Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 112, 4371-4383.
50. + thymic precursor. J. Immunol. 151, 1086-1096. (Pubitemid 23215773)
51. Lee, B.P., Mansfield, E., Hsieh, S.C., et al. (2005). Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J. Immunol. 174, 4535-4544.
52. Ma, Y., He, K.M., Garcia, B., et al. (2008). Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation. Xenotransplantation 15, 56-63. (Pubitemid 351360242)
53. Maldonado, M.A., Eisenberg, R.A., Roper, E., et al. (1995). Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181, 641-648.
54. Marra, L.E., Zhang, Z.X., Joe, B., et al. (2004). IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-alpha. J. Immunol. 172, 1028-1035. (Pubitemid 38113762)
55. McIver, Z., Serio, B., Dunbar, A., et al. (2008). Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br. J. Haematol. 141, 170-178. (Pubitemid 351406207)
56. + T cells creates double-negative cells in vivo. J Immunol. 161, 1686-1693. (Pubitemid 28387585)
57. - double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J. Autoimmun. 8, 33-45.
58. + cells based on high affinity TCR signals. J. Immunol. 162, 5747-5756. (Pubitemid 29314925)
59. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl Acad. Sci. USA 105, 10113-10118.
60. Priatel, J.J., Utting, O., and Teh, H.S. (2001). TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J. Immunol. 167, 6188-6194. (Pubitemid 33081546)
61. Riol-Blanco, L., Lazarevic, V., Awasthi, A., et al. (2010). IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J. Immunol. 184, 1710-1720.
62. Safinia, N., Sagoo, P., Lechler, R., et al. (2010). Adoptive regulatory T cell therapy: Challenges in clinical transplantation. Curr. Opin. Organ. Transplant. 15, 427-434.
63. Sakaguchi, S., Yamaguchi, T., Nomura, T., et al. (2008). Regulatory T cells and immune tolerance. Cell 133, 775-787. (Pubitemid 351707693)
64. + regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490-500.
65. Sawitzki, B., Kingsley, C.I., Oliveira, V., et al. (2005). IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201, 1925-1935. (Pubitemid 41002929)
66. Schonrich, G., Kalinke, U., Momburg, F., et al. (1991). Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65, 293-304. (Pubitemid 121006059)
67. Shevach, E.M. (2006). From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25, 195-201. (Pubitemid 44224153)
68. + T regulatory cell-mediated suppression. Immunity 30, 636-645.
69. Shlomchik, W.D. (2007). Graft-versus-host disease. Nat. Rev. Immunol. 7, 340-352. (Pubitemid 46674485)
70. Steinberg, A.D., Roths, J.B., Murphy, E.D., et al. (1980). Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/ lpr mice. J. Immunol. 125, 871-873. (Pubitemid 10045673)
71. - surface phenotype and the alpha, beta heterodimer of the T cell antigen receptor. J. Immunol. 143, 1118-1122. (Pubitemid 19211334)
72. + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage. J. Immunol. 146, 1134-1141.
73. Takahashi, T., Tanaka, M., Brannan, C.I., et al. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976. (Pubitemid 24106378)
74. Thomson, C.W., Lee, B.P., and Zhang, L. (2006). Double-negative regulatory T cells: Non-conventional regulators. Immunol. Res. 35, 163-178. (Pubitemid 44547511)
75. Treiner, E., and Lantz, O. (2006). CD1d- and MR1-restricted invariant T cells: Of mice and men. Curr. Opin. Immunol. 18, 519-526. (Pubitemid 44311447)
76. van Laethem, F., Sarafova, S.D., Park, J.H., et al. (2007). Deletion of CD4 and CD8 coreceptors permits generation of alphabetaT cells that recognize antigens independently of the MHC. Immunity 27, 735-750. (Pubitemid 350102257)
77. - T cells that escape deletion and lack regulatory activity. J. Immunol. 170, 201-209. (Pubitemid 36026141)
78. - double-negative T cells. Eur. J. Immunol. 41, 739-748.
79. + Tregs. J. Clin. Invest. 116, 2434-2441. (Pubitemid 44330142)
80. Watanabe, D., Suda, T., Hashimoto, H., et al. (1995). Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14, 12-18.
81. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., et al. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
82. Wei, B., Baker, S., Wieckiewicz, J., et al. (2010). IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells. Am. J. Transplant. 10, 69-80.
83. Wieckiewicz, J., Goto, R., and Wood, K.J. (2010). T regulatory cells and the control of alloimmunity: From characterisation to clinical application. Curr. Opin. Immunol. 22, 662-668.
84. + regulatory T cell function. Science 322, 271-275.
85. Wofsy, D., Ledbetter, J.A., Roubinian, J.R., et al. (1982). Thymic influences on autoimmunity in MRL-lpr mice. Scand J. Immunol. 16, 51-58. (Pubitemid 12089553)
86. Wood, K.J., Feng, G., Wei, B., et al. (2007). Interferon gamma: Friend or foe? Transplantation 84, S4-S5. (Pubitemid 47067533)
87. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247. (Pubitemid 37009740)
88. Yang, Y.G., Dey, B.R., Sergio, J.J., et al. (1998). Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 102, 2126-2135. (Pubitemid 29018819)
89. Young, K.J., and Zhang, L. (2002). The nature and mechanisms of DN regulatory T-cell mediated suppression. Hum. Immunol. 63, 926-934. (Pubitemid 35246773)
90. Young, K.J., Yang, L., Phillips, M.J., et al. (2002). Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 100, 3408-3414. (Pubitemid 35217094)
91. Young, K.J., DuTemple, B., Phillips, M.J., et al. (2003a). Inhibition of graft-versus-host disease by double-negative regulatory T cells. J. Immunol. 171, 134-141. (Pubitemid 36745281)
92. Young, K.J., Kay, L.S., Phillips, M.J., et al. (2003b). Antitumor activity mediated by double-negative T cells. Cancer Res. 63, 8014-8021. (Pubitemid 37466740)
93. Zhang, L., and Thomson, A.W. (2011). New partners for tolerogenic dendritic cells. Am. J. Transplant. 11, 2003-2004.
94. Zhang, Z.X., Ma, Y., Wang, H., et al. (2006). Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzymedependent, Fas-Fas ligand-independent pathway. J. Immunol. 177, 6920-6929. (Pubitemid 44715058)
95. Zhang, D., Yang, W., Degauque, N., et al. (2007). New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. Blood 109, 4071-4079. (Pubitemid 46641763)
96. Zhang, Z.X., Yang, L., Young, K.J., et al. (2000). Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 6, 782-789. (Pubitemid 30469427)
97. + T cells. Curr. Opin. Immunol. 21, 281-285.
98. + Treg cell accumulation. Transpl. Immunol. 24, 119-126.